ACRS Aclaris Therapeutics Inc

Aclaris Therapeutics Inc is a clinical-stage specialty pharmaceutical company which focuses on identifying, developing and commercializing differentiated drugs to address significant unmet needs in dermatology.

$21.28  +0.14 (0.64%)
As of 03/05/2021 15:59:23 EST     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Small cap
Health Care
Biotechnology
USA
USA
10/07/2015
51,804,258
739,951
$1,103,948,738
0.00%
SEC Edgar Online
10-Q
10-K
00461U105
US00461U1051
BYV2W40

Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
-21.64
25.52
170.31
-135.50%
-787.03%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy